Korea's LOTTE Biologics inks US-based manufacturing agreement with Alvotech to increase global supply

South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global ...

October 9, 2026 | Friday | News
Charles River and Autolomous launch Apollo Orchestrate for digital laboratory execution

Charles River Laboratories International, Inc. and Autolomous announced the launch of Apollo Orchestrate on October 6, 2...

October 8, 2026 | Thursday | News
GE HealthCare buys SOFIE Biosciences for $945 M to establish 'Final Mile' footprint for PET Radiopharmaceutical Supply in US

GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopha...

October 8, 2026 | Thursday | News
Andelyn Biosciences and PQP Group partner to streamline EU and UK supply pathways for cell and gene therapies

Andelyn Biosciences (“Andelyn”), a leading US-based patient-focused cell and gene therapy Contract Developme...

October 8, 2026 | Thursday | News
Japan's Shionogi continues rare disease expansion with acquisition of IntraBio for $2 B

Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company develo...

October 8, 2026 | Thursday | News
AstraZeneca opens new global strategic R&D centre in Massachusetts, US

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kenda...

October 7, 2026 | Wednesday | News
Germfree launches biopharmaceutical isolator for cell and gene therapy workflows

Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences,...

October 6, 2026 | Tuesday | News
Merck inks up to $2.13 B oncology deal with China's SciBrunch

Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered...

October 6, 2026 | Tuesday | News
Novartis signs licensing deal worth $7.2 B with China's Abogen for mRNA therapies

China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered...

October 7, 2026 | Wednesday | News
Taiwan's Energenesis Biomedical joins hands with Korea-based Yoo Young Pharm to develop treatment for diabetic foot ulcers

Taiwan-based Energenesis Biomedical has signed a Memorandum of Understanding (MoU) with Yoo Young Pharm (YYO), a South K...

October 6, 2026 | Tuesday | News
Eli Lilly launches ‘Nujoom Al Ghad’ to build next generation of Emirati talent in healthcare

Eli Lilly and Company (Lilly Gulf) has announced the launch of Nujoom Al Ghad, a new graduate programme designed to deve...

October 5, 2026 | Monday | News
Australia's CSL inks $1.2 B deal with Swiss firm Alentis to develop lixudebart for rare kidney and liver diseases treatment

Australia-based CSL and Swiss firm Alentis Therapeutics have entered into an exclusive global collaboration agreement to...

October 5, 2026 | Monday | News
Bayer to invest $2.2 B in new manufacturing site in US to create highly-skilled jobs

Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, US. Bui...

October 3, 2026 | Saturday | News
High-salt diet may drive fatty liver disease differently in lean people: Duke-NUS pre-clinical study

Fatty liver disease is commonly associated with obesity, yet a growing number of people with normal body weight develop ...

October 1, 2026 | Thursday | News
Vetter expands global manufacturing network with ten additional commercial filling lines

Vetter, a leading Contract Development and Manufacturing Organization (CDMO), continues to expand its commercial fill-an...

October 1, 2026 | Thursday | News
China's Hengrui Pharma inks $2.6 B deal with Novo Nordisk for Once-Weekly oral GLP-1/GIP dual receptor agonist HRS-1596

China-based Hengrui Pharma has entered into a license agreement with Novo Nordisk for HRS-1596, a phase I-ready glucagon...

October 3, 2026 | Saturday | News
Korean govt expands market entry support for dermatology companies in Europe

The Ministry of Health and Welfare, South Korea government, has announced that it will open K-Beauty experience and reta...

September 30, 2026 | Wednesday | News
Chugai and InxMed enter into worldwide license agreement for RAF-MEK Molecular Glue

Japan’s Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPY...

September 30, 2026 | Wednesday | News
Australia’s Telix Pharma receives US FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging

Australia-based Telix Pharmaceuticals has announced that the United States (US) Food and Drug Administration (FDA) has g...

September 30, 2026 | Wednesday | News
Grünenthal partners with DKSH to bring four pain medicines to eight new markets in APAC

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthc...

September 29, 2026 | Tuesday | News
European Commission grants marketing authorisation for NEZGLYAL, first pharmacological treatment for cALD

Neuraxpharm Group and Minoryx Therapeutics have announced that the European Commission has granted marketing authorisati...

September 28, 2026 | Monday | News
Deep Origin deploys AI-powered ADMET models across drug discovery programmes

Deep Origin and partners in the Pharmacological Research and Evaluation through Digital Integration and Clinical Trials ...

September 28, 2026 | Monday | News
Germfree expands executive leadership as it enters next phase of growth

Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences,...

September 28, 2026 | Monday | News
China's InnoCare inks $3.5 B deal with Eli Lilly to develop new medicines

InnoCare Pharma, a China-based biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, ha...

September 28, 2026 | Monday | News
Japan Agency for Medical Research and Development provides ¥2.8 B grant to United Immunity

United Immunity, a clinical stage biotechnology company, has raised a total of ¥2.2 billion in private financing, co...

September 28, 2026 | Monday | News